Integrated Synthesis and Characterisation of Organic Nanoparticles Using Microfluidic Technology for Drug Delivery Applications

Lead Research Organisation: University of Southampton
Department Name: Faculty of Engineering & the Environment

Abstract

Over the last decade, nanomedicine has emerged as a new field of medicine where nanoscale materials has been used to deliver a wide range of pharmaceutically active organic compounds such as drugs, genes, and imaging agents. There remain challenges, however, to synthesise and formulate organic compound based nanostructured materials, although the synthesis of inorganic nanomaterials has indeed been extensively studied over decades with good control of particle shape and size. Consequently, special formulation techniques are required to disperse the solid organic materials into water, maintain the dispersion for a certain time period, and functionalise the organic nanoparticles. Using selected experimental systems, we propose taking a radically new fast approach for making nanoscale particles and formulating them, which will not only do away with the grinding process but will also lead to a better understanding of the basic science behind product formulation allowing us to develop new improved products. The proposed method is based on the so-called Lab-on-a-Chip concept which represents the potential to shrink conventional bench chemical systems to the size of a few centimeters square. The main feature of such micro systems is the micron scale channel network with a channel width of about 100 micrometers (about the diameter of a human hair), where chemicals are brought together, using a variety of pumping techniques, for synthesis, separation or analysis. Relevant to the formulation of organic nanoparticles, the advantages of microfluidic and Lab-on-a-Chip technology will enable us to not only make particles of a very well controlled size distribution, but also integrate a number of measurement systems into the microreactor in order to monitor the process when the particles are generated, and more importantly, to institute real time feedback. It is envisaged this development will, for the first time, let us understand more about what is important in formulation science and how we can develop new strategies for new and better products in the future.

Publications

10 25 50

publication icon
Capretto L (2011) Micromixing within microfluidic devices. in Topics in current chemistry

publication icon
Capretto L (2010) Microfluidic reactors for controlled synthesis of polymeric micelles. in Journal of controlled release : official journal of the Controlled Release Society

publication icon
Capretto L (2010) Production of low cost microfluidic chips by a "shrinking" approach: applications to emulsion and microparticle production. in Journal of controlled release : official journal of the Controlled Release Society

publication icon
Mazzitelli S (2010) Process optimization for the production of alginate microparticles containing wjmscs by a design of experiments (doe) approach. in Journal of controlled release : official journal of the Controlled Release Society

 
Description (i). Optimised processes for design and fabrication of microfluidic devices;
(ii). Quantitative characterisation and modelling of microfluidic dynamics;
(iii). Controlled synthesis of nano- and micro- structured drug delivery systems;
(iv). Evaluation of nano- and micro- structured drug delivery systems.
Exploitation Route Key scientific findings and development from the Award have paved ways for the development of further proposals related to nanomedicine synthesis and drug delivery. The technology platform has also been employed by industrial partners to assist their product design and evaluation.
Sectors Chemicals,Healthcare,Pharmaceuticals and Medical Biotechnology

URL http://www.southampton.ac.uk/engineering/about/staff/xz1f06.page#publications
 
Description Impact generated from the Award include: i). Initial implementation of microfluidic technologies/systems by a medical device manufacturers for evaluating embolic devices, and by a pharmaceutical company for continuous flow synthesis of pharmaceutical intermediates; ii). Developing extensive expertise in microfluidics, and training personnel in a rapidly expanding area with a shortage of people, resulting in 2 PhDs winning the Best Medical Engineering PhD Thesis 2013, and the UK Life Sciences Skills Award for Postgraduate of the Year 2012.
First Year Of Impact 2010
Sector Healthcare,Pharmaceuticals and Medical Biotechnology
Impact Types Economic

 
Description Biocompatibles Ltd
Amount £30,000 (GBP)
Funding ID 10962/01 
Organisation BTG 
Department Biocompatibles
Sector Private
Country United Kingdom
Start 07/2012 
End 07/2016
 
Description Biocompatibles Ltd
Amount £30,000 (GBP)
Funding ID 10962/01 
Organisation BTG 
Department Biocompatibles
Sector Private
Country United Kingdom
Start 07/2012 
End 07/2016
 
Title Microfluidic devices and methods for in vitro testing of therapeutic biofluidic-related procedures 
Description The development of microfluidic devices and methods has been used for for in vitro testing of therapeutic biofluidic-related procedures such as blood flow, chemoembolisation. and stended ureteric flow. 
Type Of Material Physiological assessment or outcome measure 
Year Produced 2011 
Provided To Others? Yes  
Impact This research tool and method have been provided to an industrial collaborator for evaluating their products.